PCS provides the clinical capacity and the operating model behind it: from named pharmacists and supervision to mobilisation, governance and reporting across practices, PCNs and wider NHS programmes.
Use PCS for patient-facing clinical work by telephone or video, day-to-day medicines management, or both. We shape capacity around the work your teams need covered.
Structured pharmacist-led consultations delivered by telephone or video, adding clinical capacity without losing clear supervision or escalation.
Day-to-day prescribing and medication workload handled to agreed protocols, freeing practice clinicians for work that needs them.
PCS manages the service at network level while named pharmacists work within each practice’s systems, pathways and priorities: one operating model with local continuity.
Agree priorities, capacity, practice allocations and success measures.
Named pharmacists work within each practice’s systems, formulary, protocols and escalation routes.
Shared capacity can move to peaks, targeted cohorts and network-wide clinics.
Review utilisation and delivery, then rebalance through the agreed PCN governance route.
Named pharmacist capacity is assigned to practices for consistent weekly delivery, while PCS manages supervision and performance centrally.
A pooled pharmacy team works across the network against agreed cohorts, clinics and medicines workload, directing capacity where needed.
A practice-level baseline plus shared network capacity for peaks, programmes and cross-PCN priorities.
Where ARRS reimbursement is intended, PCS can structure the service around current Network Contract DES requirements, including role scope, qualifications, MDT integration, continuity and supervision. Alternative-provider arrangements should be intended to run for at least six months. Eligibility and reimbursement remain for the PCN and commissioner to confirm.
PCS can deliver one pharmacy specification across multiple PCNs and practices, with consistent governance and reporting while preserving local formularies, systems and escalation routes.
Agree the population, clinical scope, priorities, footprint and measures once.
Deploy through participating PCNs and practices, configured to local workflows.
Review at system level with drill-down to PCN and practice activity, quality and utilisation.
Choose the priority work. We build the consultations, protocols and capacity around your population and local pathways.
Targeted SMRs for complex polypharmacy, frailty and other agreed clinical priorities.
Planned pharmacist-led reviews delivered by telephone or video, with prescribing incorporated where agreed and appropriate.
Pharmacist-led LTC reviews delivered by telephone or video, built around local pathways, protocols and network priorities.
DOAC monitoring, high-risk medicines, Controlled Drugs reviews, deprescribing and other agreed cohorts.
Acute and repeat prescribing, medicines queries and medication tasks managed to agreed protocols.
Telephone and video pharmacist consultation capacity across agreed enhanced-access periods, aligned to the network’s access model.
Reporting is agreed before go-live, with system, PCN and practice views of activity, utilisation, quality and agreed clinical measures.
Completed activity, consultation use and capacity delivered by practice or programme.
Progress against agreed cohorts, recall lists or programme eligibility.
Monitoring activity, identified medicines risks and follow-up status within scope.
Interventions, prescribing actions and follow-up against agreed definitions.
Clinical escalations, safety events and themes for service learning.
Agreed QOF, IIF, local programme and medicines-optimisation measures can be included in reporting.
The model can be mapped to areas NHS commissioners commonly assess, without forcing a one-size-fits-all contract.
Defined scope, supervision, SOPs, escalation, audit and learning arrangements.
Transparent capacity, utilisation and agreed measures.
Configured to local pathways, MDT working, formularies and practice systems, with continuity built in.
Prioritise cohorts and geographies according to access gaps, medicines risk and health-inequality priorities.
Support practice preparation around medicines reviews, monitoring, safety alerts, prescribing audits, Controlled Drugs, SOPs and action tracking.
Procurement-specific social-value commitments can be agreed and reported.
For procurement or mobilisation, PCS can provide an evidence pack proportionate to the commissioned model.
We agree the commissioning model first, then configure local delivery, governance, access and reporting before clinical activity begins.
Agree footprint, capacity, clinical scope, expected activity, measures and intended funding route.
Confirm systems, formularies, protocols, prescribing boundaries and escalation routes.
Set named allocation, shared capacity, consultation structure, professional supervision and GP oversight where required.
Go live, review delivery and utilisation, then adjust capacity through the agreed governance route.
Practice, PCN or system-wide programme: share the footprint, priorities and capacity challenge. We’ll map the delivery model, governance and resource needed.